- Home
- ZBIO vs SENS Comparison
ZBIO vs SENS Comparison
Compare ZBIO & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- SENS
- Stock Information
- Founded
- ZBIO 2019
- SENS 1996
- Country
- ZBIO United States
- SENS United States
- Employees
- ZBIO N/A
- SENS N/A
- Industry
- ZBIO
- SENS Industrial Machinery/Components
- Sector
- ZBIO
- SENS Industrials
- Exchange
- ZBIO NYSE
- SENS Nasdaq
- Market Cap
- ZBIO 389.2M
- SENS 384.7M
- IPO Year
- ZBIO 2024
- SENS N/A
- Fundamental
- Price
- ZBIO $9.81
- SENS $0.69
- Analyst Decision
- ZBIO Strong Buy
- SENS Strong Buy
- Analyst Count
- ZBIO 7
- SENS 2
- Target Price
- ZBIO $32.29
- SENS $2.00
- AVG Volume (30 Days)
- ZBIO 260.1K
- SENS 3.2M
- Earning Date
- ZBIO 05-16-2025
- SENS 05-12-2025
- Dividend Yield
- ZBIO N/A
- SENS N/A
- EPS Growth
- ZBIO N/A
- SENS N/A
- EPS
- ZBIO N/A
- SENS N/A
- Revenue
- ZBIO $5,000,000.00
- SENS $22,472,000.00
- Revenue This Year
- ZBIO N/A
- SENS $58.74
- Revenue Next Year
- ZBIO N/A
- SENS $33.51
- P/E Ratio
- ZBIO N/A
- SENS N/A
- Revenue Growth
- ZBIO N/A
- SENS 0.37
- 52 Week Low
- ZBIO $5.83
- SENS $0.25
- 52 Week High
- ZBIO $26.25
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- SENS 55.22
- Support Level
- ZBIO N/A
- SENS $0.58
- Resistance Level
- ZBIO N/A
- SENS $0.63
- Average True Range (ATR)
- ZBIO 0.00
- SENS 0.06
- MACD
- ZBIO 0.00
- SENS 0.01
- Stochastic Oscillator
- ZBIO 0.00
- SENS 92.34
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.